Global Biopreservation Market Set for Strong Growth Through 2034, Fueled by Advances in Cell, Tissue and Biologic Storage Solutions

Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Biopreservation Market Report Global Forecast By Product, Application, Countries and Company Analysis (2026-2034)" has been added to ResearchAndMarkets.com's offering.

The global biopreservation market is projected to reach US$22.76 billion by 2034, rising from US$9.62 billion in 2025 and registering a compound annual growth rate of 10.04% from 2026 to 2034. Market expansion is being supported by increasing demand for regenerative medicine, stem cell therapies, personalized medicine, biobanking, and advanced biological sample storage technologies.

Pharmaceutical, biotechnology, and healthcare organizations are increasing investments in cell-based research, precision medicine, immunotherapies, and drug discovery. This activity is strengthening demand for cryogenic storage systems, preservation media, laboratory information management systems, automated monitoring platforms, and reliable cold-chain infrastructure. The rising prevalence of cancer, diabetes, cardiovascular conditions, and other chronic diseases is also increasing the need for high-quality biological materials used in diagnostics, clinical research, and therapeutic development.

Key Biopreservation Market Growth Drivers

Regenerative medicine and cell and gene therapy represent major growth areas for the biopreservation industry. Stem cells, tissues, and other biological materials used in these therapies require tightly controlled preservation conditions throughout research, manufacturing, transportation, and clinical administration. As the number of clinical trials and commercialized therapies grows, manufacturers are adopting advanced cryopreservation technologies to improve sample viability, post-thaw recovery, and workflow consistency.

Biobanking and precision medicine are also accelerating market development. Population biobanks, hospital repositories, academic institutions, and pharmaceutical research programs require extensive collections of blood, tissue, DNA, stem cells, and other samples. Automated storage, digital tracking, and AI-supported data management are helping operators improve capacity, sample integrity, traceability, and regulatory compliance.

Technological advances in controlled-rate freezing, vitrification, cryoprotectants, ultra-low-temperature freezers, smart sensors, and automated storage systems are further supporting adoption. In March 2025, Teknova and Pluristyx introduced PluriFreeze, an integrated cryopreservation system developed to improve cell therapy viability, increase post-thaw recovery, and shorten development timelines. Continued product innovation is expected to strengthen applications across cell therapy manufacturing, stem cell banking, vaccine development, biologics production, and structural biology research.

Market Challenges

High equipment and infrastructure costs remain a significant barrier to biopreservation market growth. Cryogenic freezers, liquid nitrogen systems, specialized facilities, backup power, cold-chain logistics, and continuous monitoring require substantial capital and operating expenditure. These costs can restrict adoption among smaller laboratories and organizations in developing markets.

Strict regulatory and quality-control requirements also create operational challenges. Organizations must validate equipment, document storage conditions, maintain sample traceability, and comply with standards governing materials intended for research, diagnostic, or therapeutic use. Differences among national regulatory frameworks can add complexity for multinational biobanks, pharmaceutical companies, and cell therapy developers.

Regional Biopreservation Market Outlook

The United States remains a leading biopreservation market due to its established biotechnology and pharmaceutical sectors, extensive clinical trial activity, advanced cold-chain infrastructure, and strong investment in regenerative medicine. The presence of major research institutions, biobanks, and cell and gene therapy manufacturers continues to stimulate demand for preservation equipment, media, and automated sample management.

Germany is a key European market, supported by its biomedical research infrastructure, engineering expertise, and active biotechnology ecosystem. Investment in stem cell research, personalized medicine, biobanking, and compliant storage systems is reinforcing the country's position in the regional market.

China is experiencing rapid growth as government programs expand biotechnology research, population health studies, regenerative medicine, and precision medicine. An increasing number of biopharmaceutical companies and clinical research organizations is driving demand for cryogenic freezers, preservation media, and automated storage platforms.

Saudi Arabia is also emerging as a developing market under Vision 2030. Investments in healthcare modernization, genetic research, medical research centers, and biobanking infrastructure are creating new opportunities, although reliance on imported equipment and specialized technical expertise remains a challenge.

Recent Biopreservation Industry Developments

• In May 2025, Azenta Inc. partnered with Form Bio to develop an integrated sequencing and AI-powered data analysis platform for AAV gene therapy development.
• In March 2025, Johnson & Johnson announced plans to invest more than US$55 billion in its U.S. operations over four years, including manufacturing facilities expected to require advanced biopreservation capabilities.
• In February 2025, Thermo Fisher Scientific introduced the Krios 5 Cryo-TEM platform with AI-driven automation for atomic-resolution imaging and structural biology research.
• In January 2025, UK Biocentre selected Azenta's BioArc Ultra automated storage system to expand sample capacity by approximately 16 million.
• In June 2023, BioLife Solutions launched a large-capacity controlled-rate freezer for high-volume autologous and allogeneic cell and gene therapy manufacturing.

Biopreservation Market Segmentation

The market is segmented by product into equipment, preservation media, and laboratory information management systems. Major applications include regenerative medicine, biobanking, and drug discovery.

Geographic coverage includes the United States, Canada, France, Germany, Italy, Spain, the United Kingdom, Belgium, the Netherlands, Turkey, China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, Brazil, Mexico, Argentina, Saudi Arabia, the United Arab Emirates, and South Africa.

Leading Biopreservation Market Companies

Major companies operating in the global biopreservation market include Thermo Fisher Scientific Inc., Cryoport Inc., Eppendorf AG, BioLife Solutions Inc., Azenta Inc., Merck KGaA, QIAGEN N.V., and Chart Industries Inc. Competitive analysis covers business operations, leadership, recent developments, strategic initiatives, financial insights, and SWOT assessments.

With expanding biobanking networks, rising cell and gene therapy activity, and continued innovation in cryogenic storage and sample management, the global biopreservation market is positioned for sustained growth through 2034.

Key Attributes:

Key Topics Covered:

1. Introduction

2. Research & Methodology
2.1 Data Source
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Research Approach
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.3 Forecast Projection Methodology

3. Executive Summary

4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges

5. Global Biopreservation Market
5.1 Historical Market Trends
5.2 Market Forecast

6. Market Share Analysis
6.1 By Product
6.2 By Application
6.3 By Countries

7. Product
7.1 Equipment
7.1.1 Market Analysis
7.1.2 Market Size & Forecast
7.2 Media
7.2.1 Market Analysis
7.2.2 Market Size & Forecast
7.3 Laboratory Information Management System (LIMS)
7.3.1 Market Analysis
7.3.2 Market Size & Forecast

8. Application
8.1 Regenerative Medicine
8.1.1 Market Analysis
8.1.2 Market Size & Forecast
8.2 Biobanking
8.2.1 Market Analysis
8.2.2 Market Size & Forecast
8.3 Drug Discovery
8.3.1 Market Analysis
8.3.2 Market Size & Forecast

9. Countries
9.1 North America
9.1.1 United States
9.1.1.1 Market Analysis
9.1.1.2 Market Size & Forecast
9.1.2 Canada
9.1.2.1 Market Analysis
9.1.2.2 Market Size & Forecast
9.2 Europe
9.2.1 France
9.2.1.1 Market Analysis
9.2.1.2 Market Size & Forecast
9.2.2 Germany
9.2.2.1 Market Analysis
9.2.2.2 Market Size & Forecast
9.2.3 Italy
9.2.3.1 Market Analysis
9.2.3.2 Market Size & Forecast
9.2.4 Spain
9.2.4.1 Market Analysis
9.2.4.2 Market Size & Forecast
9.2.5 United Kingdom
9.2.5.1 Market Analysis
9.2.5.2 Market Size & Forecast
9.2.6 Belgium
9.2.6.1 Market Analysis
9.2.6.2 Market Size & Forecast
9.2.7 Netherlands
9.2.7.1 Market Analysis
9.2.7.2 Market Size & Forecast
9.2.8 Turkey
9.2.8.1 Market Analysis
9.2.8.2 Market Size & Forecast
9.3 Asia Pacific
9.3.1 China
9.3.1.1 Market Analysis
9.3.1.2 Market Size & Forecast
9.3.2 Japan
9.3.2.1 Market Analysis
9.3.2.2 Market Size & Forecast
9.3.3 India
9.3.3.1 Market Analysis
9.3.3.2 Market Size & Forecast
9.3.4 South Korea
9.3.4.1 Market Analysis
9.3.4.2 Market Size & Forecast
9.3.5 Thailand
9.3.5.1 Market Analysis
9.3.5.2 Market Size & Forecast
9.3.6 Malaysia
9.3.6.1 Market Analysis
9.3.6.2 Market Size & Forecast
9.3.7 Indonesia
9.3.7.1 Market Analysis
9.3.7.2 Market Size & Forecast
9.3.8 Australia
9.3.8.1 Market Analysis
9.3.8.2 Market Size & Forecast
9.3.9 New Zealand
9.3.9.1 Market Analysis
9.3.9.2 Market Size & Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Analysis
9.4.1.2 Market Size & Forecast
9.4.2 Mexico
9.4.2.1 Market Analysis
9.4.2.2 Market Size & Forecast
9.4.3 Argentina
9.4.3.1 Market Analysis
9.4.3.2 Market Size & Forecast
9.5 Middle East & Africa
9.5.1 Saudi Arabia
9.5.1.1 Market Analysis
9.5.1.2 Market Size & Forecast
9.5.2 UAE
9.5.2.1 Market Analysis
9.5.2.2 Market Size & Forecast
9.5.3 South Africa
9.5.3.1 Market Analysis
9.5.3.2 Market Size & Forecast

10. Porter's Five Forces Analysis
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes

11. SWOT Analysis
11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threats

12. Key Players Analysis
12.1 Thermo Fisher Scientific Inc.
12.1.1 Overviews
12.1.2 Key Person
12.1.3 Recent Developments
12.1.4 SWOT Analysis
12.1.5 Revenue Analysis
12.2 Cryport, Inc.
12.2.1 Overviews
12.2.2 Key Person
12.2.3 Recent Developments
12.2.4 SWOT Analysis
12.2.5 Revenue Analysis
12.3 Eppendorf AG
12.3.1 Overviews
12.3.2 Key Person
12.3.3 Recent Developments
12.3.4 SWOT Analysis
12.3.5 Revenue Analysis
12.4 BioLife Solutions Inc
12.4.1 Overviews
12.4.2 Key Person
12.4.3 Recent Developments
12.4.4 SWOT Analysis
12.4.5 Revenue Analysis
12.5 Azenta Inc
12.5.1 Overviews
12.5.2 Key Person
12.5.3 Recent Developments
12.5.4 SWOT Analysis
12.5.5 Revenue Analysis
12.6 Merck KGaA
12.6.1 Overviews
12.6.2 Key Person
12.6.3 Recent Developments
12.6.4 SWOT Analysis
12.6.5 Revenue Analysis
12.7 Qiagen NV
12.7.1 Overviews
12.7.2 Key Person
12.7.3 Recent Developments
12.7.4 SWOT Analysis
12.7.5 Revenue Analysis
12.8 Chart Industries, Inc.
12.8.1 Overviews
12.8.2 Key Person
12.8.3 Recent Developments
12.8.4 SWOT Analysis
12.8.5 Revenue Analysis

Companies Featured

The companies featured in this Biopreservation market report include:

• Thermo Fisher Scientific Inc.
• Cryport, Inc.
• Eppendorf AG
• BioLife Solutions Inc
• Azenta Inc
• Merck KGaA
• Qiagen NV
• Chart Industries, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/u1g3y3

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.